ArticleInternal medicine (Tokyo, Japan)2023

Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat.

Nozomi Harai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.